Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Work
Year: 2005
Type: article
Abstract: Trastuzumab, a recombinant monoclonal antibody against HER2, has clinical activity in advanced breast cancer that overexpresses HER2. We investigated its efficacy and safety after excision of early-st... more
Source: New England Journal of Medicine
Authors Martine Piccart, Marion Procter, Brian Leyland‐Jones, Aron Goldhirsch, Michael Untch +27 more
Institutions European Institute of Oncology, McGill University, Institute of Oncology Research, Ludwig-Maximilians-Universität München, Klinik für Frauenheilkunde +25 more
Cites: 42
Cited by: 4,931
Related to: 10
FWCI: 148.1
Citation percentile (by year/subfield): 99.99
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze